Stem Cell Injection
Among various types of stem cells, Mesenchymal Stem Cells (MSCs) are widely considered as the most potent tool of cell therapy that may pass through the FDA's investigation and reach the market following to Hematopoietic Stem Cells (HSCs).
30
Years
Since Dr. Arnold Caplan gave the name to Mesenchymal Stem Cells in 1992, MSCs have been studied for cell biology, mechanisms, and broad-ranging clinical potential. With the efforts of global researchers, MSC therapeutic paradigm shifted from cell replacement to paracrine provider that presents the possibility to become a promising drug.
1,043
Clinical Trials
Based on the records on clinicaltrials.gov, there were 207 trials in the US and 1,043 trials in the worldwide associated with MSCs by Dec 2019. The conditions including Alzheimer's disease, Diabetes mellitus, System Lupus, Cardiac injuries and Aging frailty are totally 932 that shows the potential board spectrum of MSC therapeutic.
47,548
Patients
Given the data from 47,548 patients enrolled into designed trials associated with MSCs by far, the excellent safety profile and promising therapeutic efficacy inspired scientists, physicians, and entrepreneurs to discover further to make longevity dream come true.
What Our Clients Say
Name, Title
I'm a testimonial. Click to edit me and add text that says something nice about you and your services. Let your customers review you and tell their friends how great you are.